Evidence map›Paper›PMID 39039461›Full record

ReviewBMC cancer2024

Symptom impact and health-related quality of life (HRQoL) assessment by cancer stage: a narrative literature review.

Karen C Chung, Anushini Muthutantri, Grace G Goldsmith, Megan R Watts, Audrey E Brown, Donald L Patrick

Abstract readReview
In one paragraph

Review in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Health-related quality of life domains relevant to people in Europe undergoing cancer treatment: a systematic review of qualitative research.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Digital Divide Among U.S. Adults with and without Cancer: Prevalence and Associated Factors.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  7. Article
  8. Review
  9. Decision regret in patients with rectal cancer undergoing multimodal therapy.Clinical and translational radiation oncology · 2026
    Article
  10. Factors Affecting Quality of Life of Thai Cervical Cancer Patients.The journal of obstetrics and gynaecology research · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Implementing integrative nursing for oncology inpatients: a retrospective analysis of project-related routine data from 2021 to 2023.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  16. Article
  17. Listening to Australians with ovarian cancer: a cross-sectional survey investigating clinical trials awareness, information access and participation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  18. Article
  19. Socioeconomic differences in labour market attachment after breast cancer: a population-based matched cohort study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Karen C ChungGRAIL, Inc., 1525 O'Brien Dr, Menlo Park, CA, 94025, USA. kchung@grailbio.com.
Anushini MuthutantriGenesis Research Group, West One, Forth Banks, Newcastle upon Tyne, NE1 3PA, UK.
Grace G GoldsmithGenesis Research Group, West One, Forth Banks, Newcastle upon Tyne, NE1 3PA, UK.
Megan R WattsGenesis Research Group, West One, Forth Banks, Newcastle upon Tyne, NE1 3PA, UK.
Audrey E BrownGenesis Research Group, West One, Forth Banks, Newcastle upon Tyne, NE1 3PA, UK.
Donald L PatrickUniversity of Washington, 1959 NE Pacific St, Box 357660, Seattle, WA, 98195, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer stage at diagnosis is an important prognostic indicator for patient outcomes, with detection at later stages associated with increased mortality and morbidity. The impact of cancer stage on patient-reported outcomes is poorly understood. This research aimed to understand symptom burden and health related quality of life (HRQoL) impact by cancer stage for ten cancer types: 1) ovarian, 2) lung, 3) pancreatic, 4) esophageal, 5) stomach, 6) head and neck, 7) colorectal, 8) anal, 9) cervical, and 10) liver and bile duct.

methodsTen narrative literature reviews were performed to identify and collate published literature on patient burden at different stages of disease progression. Literature searches were conducted using an AI-assisted platform to identify relevant articles published in the last five (2017-2022) or ten years (2012-2022) where articles were limited. Conference abstracts were searched for the last two years (2020-2022). The geographic scope was limited to the United States, Canada, Europe, and global studies, and only journal articles written in English were included.

resultsA total of 26 studies with results stratified by cancer stage at diagnosis (and before treatment) were selected for the cancer types of lung, pancreatic, esophageal, stomach, head and neck, colorectal, anal, and cervical cancers. Two cancer types, ovarian cancer, and liver and bile duct cancer did not return any search results with outcomes stratified by disease stage. A general trend was observed for worse patient-reported outcomes in patients with cancer diagnosed at an advanced stage of disease compared with diagnosis at an earlier stage. Advanced disease stage was associated with greater symptom impact including general physical impairments such as pain, fatigue, and interference with functioning, as well as disease/region-specific symptom burden. Poorer HRQoL was also associated with advanced disease with commonly reported symptoms including anxiety and depression.

conclusionsOverall, the general trend for greater symptom burden and poorer HRQoL seen in late stage versus early-stage disease across the included cancer types supports the importance for early diagnosis and treatment to improve patient survival and decrease negative impacts on disease burden and HRQoL.

Indexed as

NeoplasmsNeoplasm StagingQuality of LifeFemaleHumansCancerCancer screeningEarly detectionHealth related quality of lifePatient reported outcomes

Identifiers

PMID39039461
PMCPMC11265440

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.